INTS
TOTAL INVALIDATION OF REG EXT PROTECTION SENT TO IB
08/06/2026
Back to search
Official data from USPTO
CLIPHALER
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: United States
Quick snapshot
CLIPHALER
ST13
US500000079226716Class
5, 10
Filing
79226716
Registration
5582976
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
35
Latest update
08/06/2026
Trademark type
Word
Nice classes
5, 10
Filing date
10/05/2017
Registration date
10/16/2018
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
05/02/2025
Last transaction
08/06/2026
Responsible office
United States Patent and Trademark Office
Status code
709
Official register
Principal Register
Drawing code
4
Owner type
27
Owner location
64665 Alsbach-Hähnlein, DE
Examiner
SEVERSON, JUSTIN
Law office
M20
Current location
PUBLICATION AND ISSUE SECTION
Holders and representatives
Holders
Köhler Pharma GmbH
Representatives
mepat Patentanwälte Partnerschaftsgesellschaft
Technical classification
Nice Classes
Class 5Class 10
Vienna Codes
No Vienna codes available.
Goods and services
Class 5
Pharmaceutical preparations and substancesinhalants to be taken orally or nasally for the treatment of respiratory diseasesproblems and disorderscancerallergic reactions and for respiratory stimulation; drugs for medical purposesinhalants to be taken orally or nasally nasally for the treatment of respiratory diseasesproblems and disorderscancerallergic reactions and for respiratory stimulation
Class 10
Surgical and physician apparatus and instruments for orally or nasally taken pharmaceutical preparations and for substances and for drugs for medical purposes; medical apparatus for facilitating the orally or nasally inhalation of pharmaceutical preparations; inhalers for substances for medical purposes; inhalers for drugs for medical purposes
Publications
History of USPTO decisions and trademark events.
35 publications found
INPC
INVALIDATION PROCESSED
08/06/2026
INTR
TOTAL INVALIDATION OF REG EXT PROTECTION CREATED
01/02/2026
C71T
CANCELLED SECTION 71
05/02/2025
NREP
NEW REPRESENTATIVE AT IB RECEIVED
09/11/2020
NREP
NEW REPRESENTATIVE AT IB RECEIVED
07/23/2020
FINO
FINAL DECISION TRANSACTION PROCESSED BY IB
02/15/2019
FICS
FINAL DISPOSITION NOTICE SENT TO IB
01/30/2019
FIMP
FINAL DISPOSITION PROCESSED
01/30/2019
FICR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
01/16/2019
R.PR
REGISTERED-PRINCIPAL REGISTER
10/16/2018
PUBO
PUBLISHED FOR OPPOSITION
07/31/2018
GPNX
NOTIFICATION PROCESSED BY IB
07/27/2018
OPNS
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
07/11/2018
OP2R
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
07/11/2018
NPUB
NOTICE OF PUBLICATION
07/11/2018
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
06/21/2018
ACEC
AMENDMENT FROM APPLICANT ENTERED
06/07/2018
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
06/07/2018
FAXX
FAX RECEIVED
05/30/2018
CNRT
NON-FINAL ACTION MAILED
05/15/2018
CNRT
NON-FINAL ACTION WRITTEN
05/14/2018
ACEC
AMENDMENT FROM APPLICANT ENTERED
04/23/2018
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
04/23/2018
ALIE
ASSIGNED TO LIE
04/19/2018
FAXX
FAX RECEIVED
04/10/2018
RFNT
REFUSAL PROCESSED BY IB
03/24/2018
RFCS
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
03/08/2018
RFRR
REFUSAL PROCESSED BY MPU
03/08/2018
RFCR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
03/02/2018
CNRT
NON-FINAL ACTION WRITTEN
03/01/2018
MAFR
APPLICATION FILING RECEIPT MAILED
02/27/2018
DOCK
ASSIGNED TO EXAMINER
02/23/2018
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
02/23/2018
REPR
SN ASSIGNED FOR SECT 66A APPL FROM IB
02/15/2018
Continuous trademark protection
Get notified about every new filing that threatens CLIPHALER or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.